5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS
5,6-Bisaryl-2-pyridine-carboxamide compounds (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. 5,6-Bisaryl-2-pyridine-carboxamide compounds of formula (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. X, Y 1N or CR3; R3 : H, halo, alkyl or...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; slv |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | VERNIERES JEAN-CLAUDE JANIAK PHILIP FOSSEY VALERIE LASSALLE GILBERT PETIT FREDERIC ALTENBURGER JEAN-MICHEL |
description | 5,6-Bisaryl-2-pyridine-carboxamide compounds (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. 5,6-Bisaryl-2-pyridine-carboxamide compounds of formula (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. X, Y 1N or CR3; R3 : H, halo, alkyl or alkoxy; A : (hetero)aryl or heterocycloalkyl like phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl or pyrrolidinone (all optionally substituted by 1-3 groups like halo, (fluoro)alkyl, OH, alkoxy, -NRR1a, -NR-CO-alkyl, -SO- or -SO 2-alkyl); W 1bond or (cyclo)alkylene (optionally substituted by 1 or 2 groups like halo, alkyl, OH or alkoxy); B 1-NR4R5 or heterocyclic ring of formula (a); either R4, R5 : (cyclo)alkyl or fluoroalkyl; or NR4R5 : 5 or 6 membered ring e.g. pyrrolidinyl or piperidinyl (optionally substituted by alkyl); m, n : 0-2; R1a, R6, R7 : H or alkyl; either R1, R2 : H, (cyclo)alkyl, phenyl, benzyl or -CH 2-indolyl (all optionally substituted by halo, (fluoro)alkyl, OH or -O-CO-alkyl); or CR1R2 : mono-/polycyclic ring like cycloalkyl, indanyl, tetrahydropyranyl, piperidine, tetrahydronaphtyl, bicyclo[2.2.1]heptyl, bicyclo[3.3.1]nonyl or adamantyl (all optionally substituted by halo, (fluoro)alkyl, OH, alkoxy, formyl or acetyl); and p : 0-1. [Image] [Image] ACTIVITY : Cardiant; Vasotropic; Antiinflammatory; Antiarteriosclerotic; Respiratory-Gen.; Nephrotropic; Antidiabetic; Hypotensive. MECHANISM OF ACTION : Urotensine II receptor antagonist. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI2059508TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI2059508TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI2059508TT13</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeod4r6BqlR0OU2nOqBJmEyLXYlIXIkW6iE8tgU9gKv_H-_zx8k7T9e6oADcHvRS-5apJIvaABfuBEcqUZXI1IBQgyFVntEDD-SsAlsq8P5A5suyR0ZXKfpW8FgLmaAgqJqdoA2DIVKMBr04Hg4Eds5SkDBNRrfLvY-zX06SeYVi9jp2z3Psu8s1PuLrHGiZ5ds824gsVv9sPmTvPxQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS</title><source>esp@cenet</source><creator>VERNIERES JEAN-CLAUDE ; JANIAK PHILIP ; FOSSEY VALERIE ; LASSALLE GILBERT ; PETIT FREDERIC ; ALTENBURGER JEAN-MICHEL</creator><creatorcontrib>VERNIERES JEAN-CLAUDE ; JANIAK PHILIP ; FOSSEY VALERIE ; LASSALLE GILBERT ; PETIT FREDERIC ; ALTENBURGER JEAN-MICHEL</creatorcontrib><description>5,6-Bisaryl-2-pyridine-carboxamide compounds (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. 5,6-Bisaryl-2-pyridine-carboxamide compounds of formula (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. X, Y 1N or CR3; R3 : H, halo, alkyl or alkoxy; A : (hetero)aryl or heterocycloalkyl like phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl or pyrrolidinone (all optionally substituted by 1-3 groups like halo, (fluoro)alkyl, OH, alkoxy, -NRR1a, -NR-CO-alkyl, -SO- or -SO 2-alkyl); W 1bond or (cyclo)alkylene (optionally substituted by 1 or 2 groups like halo, alkyl, OH or alkoxy); B 1-NR4R5 or heterocyclic ring of formula (a); either R4, R5 : (cyclo)alkyl or fluoroalkyl; or NR4R5 : 5 or 6 membered ring e.g. pyrrolidinyl or piperidinyl (optionally substituted by alkyl); m, n : 0-2; R1a, R6, R7 : H or alkyl; either R1, R2 : H, (cyclo)alkyl, phenyl, benzyl or -CH 2-indolyl (all optionally substituted by halo, (fluoro)alkyl, OH or -O-CO-alkyl); or CR1R2 : mono-/polycyclic ring like cycloalkyl, indanyl, tetrahydropyranyl, piperidine, tetrahydronaphtyl, bicyclo[2.2.1]heptyl, bicyclo[3.3.1]nonyl or adamantyl (all optionally substituted by halo, (fluoro)alkyl, OH, alkoxy, formyl or acetyl); and p : 0-1. [Image] [Image] ACTIVITY : Cardiant; Vasotropic; Antiinflammatory; Antiarteriosclerotic; Respiratory-Gen.; Nephrotropic; Antidiabetic; Hypotensive. MECHANISM OF ACTION : Urotensine II receptor antagonist.</description><language>eng ; slv</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120831&DB=EPODOC&CC=SI&NR=2059508T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120831&DB=EPODOC&CC=SI&NR=2059508T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>VERNIERES JEAN-CLAUDE</creatorcontrib><creatorcontrib>JANIAK PHILIP</creatorcontrib><creatorcontrib>FOSSEY VALERIE</creatorcontrib><creatorcontrib>LASSALLE GILBERT</creatorcontrib><creatorcontrib>PETIT FREDERIC</creatorcontrib><creatorcontrib>ALTENBURGER JEAN-MICHEL</creatorcontrib><title>5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS</title><description>5,6-Bisaryl-2-pyridine-carboxamide compounds (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. 5,6-Bisaryl-2-pyridine-carboxamide compounds of formula (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. X, Y 1N or CR3; R3 : H, halo, alkyl or alkoxy; A : (hetero)aryl or heterocycloalkyl like phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl or pyrrolidinone (all optionally substituted by 1-3 groups like halo, (fluoro)alkyl, OH, alkoxy, -NRR1a, -NR-CO-alkyl, -SO- or -SO 2-alkyl); W 1bond or (cyclo)alkylene (optionally substituted by 1 or 2 groups like halo, alkyl, OH or alkoxy); B 1-NR4R5 or heterocyclic ring of formula (a); either R4, R5 : (cyclo)alkyl or fluoroalkyl; or NR4R5 : 5 or 6 membered ring e.g. pyrrolidinyl or piperidinyl (optionally substituted by alkyl); m, n : 0-2; R1a, R6, R7 : H or alkyl; either R1, R2 : H, (cyclo)alkyl, phenyl, benzyl or -CH 2-indolyl (all optionally substituted by halo, (fluoro)alkyl, OH or -O-CO-alkyl); or CR1R2 : mono-/polycyclic ring like cycloalkyl, indanyl, tetrahydropyranyl, piperidine, tetrahydronaphtyl, bicyclo[2.2.1]heptyl, bicyclo[3.3.1]nonyl or adamantyl (all optionally substituted by halo, (fluoro)alkyl, OH, alkoxy, formyl or acetyl); and p : 0-1. [Image] [Image] ACTIVITY : Cardiant; Vasotropic; Antiinflammatory; Antiarteriosclerotic; Respiratory-Gen.; Nephrotropic; Antidiabetic; Hypotensive. MECHANISM OF ACTION : Urotensine II receptor antagonist.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeod4r6BqlR0OU2nOqBJmEyLXYlIXIkW6iE8tgU9gKv_H-_zx8k7T9e6oADcHvRS-5apJIvaABfuBEcqUZXI1IBQgyFVntEDD-SsAlsq8P5A5suyR0ZXKfpW8FgLmaAgqJqdoA2DIVKMBr04Hg4Eds5SkDBNRrfLvY-zX06SeYVi9jp2z3Psu8s1PuLrHGiZ5ds824gsVv9sPmTvPxQ</recordid><startdate>20120831</startdate><enddate>20120831</enddate><creator>VERNIERES JEAN-CLAUDE</creator><creator>JANIAK PHILIP</creator><creator>FOSSEY VALERIE</creator><creator>LASSALLE GILBERT</creator><creator>PETIT FREDERIC</creator><creator>ALTENBURGER JEAN-MICHEL</creator><scope>EVB</scope></search><sort><creationdate>20120831</creationdate><title>5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS</title><author>VERNIERES JEAN-CLAUDE ; JANIAK PHILIP ; FOSSEY VALERIE ; LASSALLE GILBERT ; PETIT FREDERIC ; ALTENBURGER JEAN-MICHEL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI2059508TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>VERNIERES JEAN-CLAUDE</creatorcontrib><creatorcontrib>JANIAK PHILIP</creatorcontrib><creatorcontrib>FOSSEY VALERIE</creatorcontrib><creatorcontrib>LASSALLE GILBERT</creatorcontrib><creatorcontrib>PETIT FREDERIC</creatorcontrib><creatorcontrib>ALTENBURGER JEAN-MICHEL</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>VERNIERES JEAN-CLAUDE</au><au>JANIAK PHILIP</au><au>FOSSEY VALERIE</au><au>LASSALLE GILBERT</au><au>PETIT FREDERIC</au><au>ALTENBURGER JEAN-MICHEL</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS</title><date>2012-08-31</date><risdate>2012</risdate><abstract>5,6-Bisaryl-2-pyridine-carboxamide compounds (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. 5,6-Bisaryl-2-pyridine-carboxamide compounds of formula (I) and their salts, enantiomers, diastereoisomers or racemic mixture, are new. X, Y 1N or CR3; R3 : H, halo, alkyl or alkoxy; A : (hetero)aryl or heterocycloalkyl like phenyl, thienyl, thiazolyl, pyridinyl, pyrimidinyl, pyridazinyl, pyrazinyl, pyrazolyl or pyrrolidinone (all optionally substituted by 1-3 groups like halo, (fluoro)alkyl, OH, alkoxy, -NRR1a, -NR-CO-alkyl, -SO- or -SO 2-alkyl); W 1bond or (cyclo)alkylene (optionally substituted by 1 or 2 groups like halo, alkyl, OH or alkoxy); B 1-NR4R5 or heterocyclic ring of formula (a); either R4, R5 : (cyclo)alkyl or fluoroalkyl; or NR4R5 : 5 or 6 membered ring e.g. pyrrolidinyl or piperidinyl (optionally substituted by alkyl); m, n : 0-2; R1a, R6, R7 : H or alkyl; either R1, R2 : H, (cyclo)alkyl, phenyl, benzyl or -CH 2-indolyl (all optionally substituted by halo, (fluoro)alkyl, OH or -O-CO-alkyl); or CR1R2 : mono-/polycyclic ring like cycloalkyl, indanyl, tetrahydropyranyl, piperidine, tetrahydronaphtyl, bicyclo[2.2.1]heptyl, bicyclo[3.3.1]nonyl or adamantyl (all optionally substituted by halo, (fluoro)alkyl, OH, alkoxy, formyl or acetyl); and p : 0-1. [Image] [Image] ACTIVITY : Cardiant; Vasotropic; Antiinflammatory; Antiarteriosclerotic; Respiratory-Gen.; Nephrotropic; Antidiabetic; Hypotensive. MECHANISM OF ACTION : Urotensine II receptor antagonist.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; slv |
recordid | cdi_epo_espacenet_SI2059508TT1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | 5,6-BISARYL-2-PYRIDINE-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS AS UROTENSIN II RECEPTOR ANTAGONISTS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T20%3A16%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=VERNIERES%20JEAN-CLAUDE&rft.date=2012-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI2059508TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |